Unknown

Dataset Information

0

The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.


ABSTRACT: Anaplastic thyroid cancer (ATC) remains refractory to available surgical and medical interventions. Histone deacetylase (HDAC) inhibitors are an emerging targeted therapy with antiproliferative activity in a variety of thyroid cancer cell lines. Thailandepsin A (TDP-A) is a novel class I HDAC inhibitor whose efficacy remains largely unknown in ATC. Therefore, we aimed to characterize the effect of TDP-A on ATC.Human-derived ATC cells were treated with TDP-A. IC50 was determined by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) rapid colorimetric assay, and cell proliferation was measured by viable cell count. Molecular mechanisms of cell growth inhibition were investigated by Western blot analysis of canonical apoptosis markers, intrinsic and extrinsic apoptosis regulators, and cell cycle regulatory proteins. Cell cycle staging was determined with propidium iodide flow cytometry.TDP-A dose- and time-dependently reduced cell proliferation. Increased cleavage of the apoptosis markers Caspase-9, Caspase-3, and poly adenosine diphosphate ribose polymerase were observed with TDP-A treatment. Levels of the intrinsic apoptosis pathway proteins BAD, Bcl-XL, and BAX remained unchanged. Importantly, the extrinsic apoptosis activator cleaved Caspase-8 increased dose-dependently, and the antiapoptotic proteins Survivin and Bcl-2 decreased. Among the cell cycle regulatory proteins, levels of CDK inhibitors p21/WAF1 and p27/KIP increased. Flow cytometry showed that ATC cells were arrested in G2/M phase with diminished S phase after TDP-A treatment.TDP-A induces a notable dose- and time-dependent antiproliferative effect on ATC, which is mainly attributed to extrinsic apoptosis with concomitant cell cycle arrest. TDP-A therefore warrants further preclinical and clinical investigations.

SUBMITTER: Weinlander E 

PROVIDER: S-EPMC4063213 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.

Weinlander Eric E   Somnay Yash Y   Harrison April D AD   Wang Cheng C   Cheng Yi-Qiang YQ   Jaskula-Sztul Renata R   Yu Xiao-Min XM   Chen Herbert H  

The Journal of surgical research 20140228 1


<h4>Background</h4>Anaplastic thyroid cancer (ATC) remains refractory to available surgical and medical interventions. Histone deacetylase (HDAC) inhibitors are an emerging targeted therapy with antiproliferative activity in a variety of thyroid cancer cell lines. Thailandepsin A (TDP-A) is a novel class I HDAC inhibitor whose efficacy remains largely unknown in ATC. Therefore, we aimed to characterize the effect of TDP-A on ATC.<h4>Methods</h4>Human-derived ATC cells were treated with TDP-A. IC  ...[more]

Similar Datasets

| S-EPMC5642598 | biostudies-literature
| S-EPMC3796495 | biostudies-literature
| S-EPMC5059567 | biostudies-literature
| S-EPMC6374448 | biostudies-literature
| S-EPMC7324504 | biostudies-literature
| S-EPMC6986377 | biostudies-literature
| S-EPMC4234873 | biostudies-literature
| S-EPMC4221369 | biostudies-literature
| S-EPMC4468708 | biostudies-other
| S-EPMC5354719 | biostudies-literature